Silo Pharma, Inc. (SILO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol SILO
- Company Silo Pharma, Inc.
- Price $0.33
- Changes Percentage 19.06
- Change 0.05
- Day Low $0.3
- Day High $0.34
- Year High $1.49
- Year Low $0.22
- Market Cap $2,664,268
- Price Avg 50 EMA (D) $0.36
- Price Avg 200 EMA (D) $0.55
- Exchange NASDAQ
- Volume 26,237,709
- Average Volume 182,968
- Open $0.34
- Previous Close $0.28
- EPS -0.91
- PE -0.37
- Earnings Announcement 2026-03-27 12:00:00
- Shares Outstanding $7,957,790
Company brief: SILO PHARMA, INC. (SILO )
- Healthcare
- Biotechnology
- Mr. Eric Weisblum
- https://silopharma.com
- US
- N/A
- 01-08-2021
- US82711P2011
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.